Lupin Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VILAZODONE HYDROCHLORIDE, with a corresponding US DMF Number 28401.
Remarkably, this DMF maintains an Active status since its submission on July 30, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 13, 2015, and payment made on December 11, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II